Annual Retained Earnings
-$924.39 M
-$402.27 M-77.04%
31 December 2023
Summary:
Vaxcyte annual retained earnings is currently -$924.39 million, with the most recent change of -$402.27 million (-77.04%) on 31 December 2023. During the last 3 years, it has fallen by -$725.83 million (-365.54%). PCVX annual retained earnings is now -1464.83% below its all-time high of -$59.07 million, reached on 31 December 2018.PCVX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.25 B
-$103.12 M-8.98%
30 September 2024
Summary:
Vaxcyte quarterly retained earnings is currently -$1.25 billion, with the most recent change of -$103.12 million (-8.98%) on 30 September 2024. Over the past year, it has dropped by -$507.65 million (-68.27%). PCVX quarterly retained earnings is now -1044.28% below its all-time high of -$109.35 million, reached on 31 December 2019.PCVX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCVX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -77.0% | -68.3% |
| 3 y3 years | -365.5% | -363.3% |
| 5 y5 years | -1464.8% | - |
PCVX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -365.5% | at low | -363.3% | at low |
| 5 y | 5 years | -1464.8% | at low | -1044.3% | at low |
| alltime | all time | -1464.8% | at low | -1044.3% | at low |
Vaxcyte Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.25 B(+9.0%) |
| June 2024 | - | -$1.15 B(+12.6%) |
| Mar 2024 | - | -$1.02 B(+10.3%) |
| Dec 2023 | -$924.39 M(+77.0%) | -$924.39 M(+24.3%) |
| Sept 2023 | - | -$743.59 M(+14.2%) |
| June 2023 | - | -$650.93 M(+11.7%) |
| Mar 2023 | - | -$582.59 M(+11.6%) |
| Dec 2022 | -$522.13 M | -$522.13 M(+17.6%) |
| Sept 2022 | - | -$444.08 M(+15.0%) |
| June 2022 | - | -$386.16 M(+14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$337.63 M(+13.1%) |
| Dec 2021 | -$298.64 M(+50.4%) | -$298.64 M(+10.6%) |
| Sept 2021 | - | -$270.08 M(+10.9%) |
| June 2021 | - | -$243.46 M(+10.8%) |
| Mar 2021 | - | -$219.78 M(+10.7%) |
| Dec 2020 | -$198.56 M(+81.6%) | -$198.56 M(+11.7%) |
| Sept 2020 | - | -$177.83 M(+13.4%) |
| June 2020 | - | -$156.81 M(+14.9%) |
| Mar 2020 | - | -$136.49 M(+24.8%) |
| Dec 2019 | -$109.35 M(+85.1%) | -$109.35 M |
| Dec 2018 | -$59.07 M | - |
FAQ
- What is Vaxcyte annual retained earnings?
- What is the all time high annual retained earnings for Vaxcyte?
- What is Vaxcyte annual retained earnings year-on-year change?
- What is Vaxcyte quarterly retained earnings?
- What is the all time high quarterly retained earnings for Vaxcyte?
- What is Vaxcyte quarterly retained earnings year-on-year change?
What is Vaxcyte annual retained earnings?
The current annual retained earnings of PCVX is -$924.39 M
What is the all time high annual retained earnings for Vaxcyte?
Vaxcyte all-time high annual retained earnings is -$59.07 M
What is Vaxcyte annual retained earnings year-on-year change?
Over the past year, PCVX annual retained earnings has changed by -$402.27 M (-77.04%)
What is Vaxcyte quarterly retained earnings?
The current quarterly retained earnings of PCVX is -$1.25 B
What is the all time high quarterly retained earnings for Vaxcyte?
Vaxcyte all-time high quarterly retained earnings is -$109.35 M
What is Vaxcyte quarterly retained earnings year-on-year change?
Over the past year, PCVX quarterly retained earnings has changed by -$507.65 M (-68.27%)